Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 Feb 15;330(Pt 1):89–94. doi: 10.1042/bj3300089

Down-regulation by prostaglandins of type-II phospholipase A2 expression in guinea-pig alveolar macrophages: a possible involvement of cAMP.

D Vial 1, L Arbibe 1, N Havet 1, C Dumarey 1, B Vargaftig 1, L Touqui 1
PMCID: PMC1219112  PMID: 9461495

Abstract

We have demonstrated previously that isolated guinea-pig alveolar macrophages (AM) synthesize type-II phospholipase A2 (PLA2-II) through a tumour necrosis factor-alpha (TNF-alpha)-dependent process. This synthesis is enhanced by lipopolysaccharide (LPS) and accompanied by a release of prostaglandin E2 (PGE2) into the medium. Because agents elevating intracellular cAMP, such as PGE2, have been shown to stimulate PLA2-II expression in various cell types, we investigated the modulation of PLA2-II synthesis by cAMP in AM. Surprisingly, incubation of AM with PGE2, dibutyryl-cAMP, cholera toxin or rolipram (an inhibitor of specific cAMP-phosphodiesterase) inhibited both basal and LPS-stimulated PLA2-II expression. The inhibitory effect of PGE2 was observed at concentrations similar to those released by AM. Moreover, treatment of AM with either aspirin or neutralizing PGE2 monoclonal antibody stimulated PLA2-II synthesis. These effects were closely correlated with the ability of these agents to modulate TNF-alpha release, which was decreased by dibutyryl-cAMP and exogenous PGE2, whereas neutralizing PGE2 antibody markedly increased this release. Hence, in contrast to other cell systems, we report that: (i) agents elevating intracellular cAMP levels down-regulate both basal and LPS-induced PLA2-II synthesis, (ii) prostaglandins exert a negative feedback effect on this synthesis, probably through an elevation of intracellular cAMP levels, and (iii) inhibition of TNF-alpha release may account, at least in part, for the down-regulation of PLA2-II expression by endogenously produced prostaglandins and cAMP-elevating agents.

Full Text

The Full Text of this article is available as a PDF (275.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbibe L., Vial D., Rosinski-Chupin I., Havet N., Huerre M., Vargaftig B. B., Touqui L. Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis. J Immunol. 1997 Jul 1;159(1):391–400. [PubMed] [Google Scholar]
  2. Barbour S. E., Dennis E. A. Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388D1 cells. J Biol Chem. 1993 Oct 15;268(29):21875–21882. [PubMed] [Google Scholar]
  3. Björnberg F., Lantz M., Olsson I., Gullberg U. Mechanisms involved in the processing of the p55 and the p75 tumor necrosis factor (TNF) receptors to soluble receptor forms. Lymphokine Cytokine Res. 1994 Jun;13(3):203–211. [PubMed] [Google Scholar]
  4. Braquet P., Touqui L., Shen T. Y., Vargaftig B. B. Perspectives in platelet-activating factor research. Pharmacol Rev. 1987 Jun;39(2):97–145. [PubMed] [Google Scholar]
  5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  6. Church G. M., Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984 Apr;81(7):1991–1995. doi: 10.1073/pnas.81.7.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. David F., Sommé G., Provost-Wisner A., Roth C., Astoin M., Dray F., Thèze J. Characterization of monoclonal antibodies against prostaglandin E2: fine specificity and neutralization of biological effects. Mol Immunol. 1985 Mar;22(3):339–346. doi: 10.1016/0161-5890(85)90170-1. [DOI] [PubMed] [Google Scholar]
  8. Dennis E. A. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 1994 May 6;269(18):13057–13060. [PubMed] [Google Scholar]
  9. Devlin R. B., McDonnell W. F., Becker S., Madden M. C., McGee M. P., Perez R., Hatch G., House D. E., Koren H. S. Time-dependent changes of inflammatory mediators in the lungs of humans exposed to 0.4 ppm ozone for 2 hr: a comparison of mediators found in bronchoalveolar lavage fluid 1 and 18 hr after exposure. Toxicol Appl Pharmacol. 1996 May;138(1):176–185. doi: 10.1006/taap.1996.0111. [DOI] [PubMed] [Google Scholar]
  10. Dray F., Gerozissis K., Kouznetzova B., Mamas S., Pradelles P., Trugnan G. New approach to the RIA of prostaglandins and related compounds using iodinated tracers. Adv Prostaglandin Thromboxane Res. 1980;6:167–180. [PubMed] [Google Scholar]
  11. Fonteh A. N., Bass D. A., Marshall L. A., Seeds M., Samet J. M., Chilton F. H. Evidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. J Immunol. 1994 Jun 1;152(11):5438–5446. [PubMed] [Google Scholar]
  12. Glaser K. B., Mobilio D., Chang J. Y., Senko N. Phospholipase A2 enzymes: regulation and inhibition. Trends Pharmacol Sci. 1993 Mar;14(3):92–98. doi: 10.1016/0165-6147(93)90071-q. [DOI] [PubMed] [Google Scholar]
  13. Goncalves de Moraes V. L., Boris Vargaftig B., Lefort J., Meager A., Chignard M. Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung. Br J Pharmacol. 1996 Apr;117(8):1792–1796. doi: 10.1111/j.1476-5381.1996.tb15356.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hatmi M., Havet N., Vargaftig B. B., Bachelet M. Azelastine potentiates the prostaglandin-induced increase of cyclic AMP content in human platelets and in guinea-pig alveolar macrophages. Prostaglandins. 1992 May;43(5):457–472. doi: 10.1016/0090-6980(92)90128-g. [DOI] [PubMed] [Google Scholar]
  15. Hidi R., Vargaftig B. B., Touqui L. Increased synthesis and secretion of a 14-kDa phospholipase A2 by guinea pig alveolar macrophages. Dissociation from arachidonic acid liberation and modulation by dexamethasone. J Immunol. 1993 Nov 15;151(10):5613–5623. [PubMed] [Google Scholar]
  16. Kadiri C., Masliah J., Bachelet M., Vargaftig B. B., Béréziat G. Phospholipase A2-mediated release of arachidonic acid in stimulated guinea pig alveolar macrophages: interaction with lipid mediators and cyclic AMP. J Cell Biochem. 1989 Jun;40(2):157–164. doi: 10.1002/jcb.240400204. [DOI] [PubMed] [Google Scholar]
  17. Kambayashi T., Jacob C. O., Zhou D., Mazurek N., Fong M., Strassmann G. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. J Immunol. 1995 Nov 15;155(10):4909–4916. [PubMed] [Google Scholar]
  18. Konieczkowski M., Sedor J. R. Cell-specific regulation of type II phospholipase A2 expression in rat mesangial cells. J Clin Invest. 1993 Nov;92(5):2524–2532. doi: 10.1172/JCI116861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kunkel S. L., Wiggins R. C., Chensue S. W., Larrick J. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem Biophys Res Commun. 1986 May 29;137(1):404–410. doi: 10.1016/0006-291x(86)91224-6. [DOI] [PubMed] [Google Scholar]
  20. Lehmmann V., Benninghoff B., Dröge W. Tumor necrosis factor-induced activation of peritoneal macrophages is regulated by prostaglandin E2 and cAMP. J Immunol. 1988 Jul 15;141(2):587–591. [PubMed] [Google Scholar]
  21. Ljungman A. G., Tagesson C., Lindahl M. Endotoxin stimulates the expression of group II PLA2 in rat lung in vivo and in isolated perfused lungs. Am J Physiol. 1996 May;270(5 Pt 1):L752–L760. doi: 10.1152/ajplung.1996.270.5.L752. [DOI] [PubMed] [Google Scholar]
  22. McCord M., Bolognese B., Marshall L. A. Prostaglandin E2 requirement for transforming growth factor beta 1 inhibition of elicited macrophage 14 kDa phospholipase A2 release. Br J Pharmacol. 1995 Nov;116(6):2575–2581. doi: 10.1111/j.1476-5381.1995.tb17210.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Miyake A., Yamamoto H., Enomori T., Kawashima H. Exogenous group II phospholipase A2 induces prostaglandin E2 production in mouse peritoneal macrophages. Eur J Pharmacol. 1994 Feb 21;253(1-2):155–161. doi: 10.1016/0014-2999(94)90770-6. [DOI] [PubMed] [Google Scholar]
  24. Mühl H., Geiger T., Pignat W., Märki F., van den Bosch H., Vosbeck K., Pfeilschifter J. PDGF suppresses the activation of group II phospholipase A2 gene expression by interleukin 1 and forskolin in mesangial cells. FEBS Lett. 1991 Oct 21;291(2):249–252. doi: 10.1016/0014-5793(91)81295-j. [DOI] [PubMed] [Google Scholar]
  25. Nakano T., Ohara O., Teraoka H., Arita H. Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells. FEBS Lett. 1990 Feb 12;261(1):171–174. doi: 10.1016/0014-5793(90)80663-4. [DOI] [PubMed] [Google Scholar]
  26. Offenstadt G., Pinta P., Masliah J., Alcindor L. G., Héricord P., Amstutz P. Phospholipase and prophospholipase activities in bronchoalveolar lavage fluid in severe acute pulmonary disease with or without ARDS. Intensive Care Med. 1981;7(6):285–290. doi: 10.1007/BF01709723. [DOI] [PubMed] [Google Scholar]
  27. Ohara O., Ishizaki J., Nakano T., Arita H., Teraoka H. A simple and sensitive method for determining transcription initiation site: identification of two transcription initiation sites in rat group II phospholipase A2 gene. Nucleic Acids Res. 1990 Dec 11;18(23):6997–7002. doi: 10.1093/nar/18.23.6997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Oka S., Arita H. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J Biol Chem. 1991 May 25;266(15):9956–9960. [PubMed] [Google Scholar]
  29. Pfeilschifter J., Leighton J., Pignat W., Märki F., Vosbeck K. Cyclic AMP mimics, but does not mediate, interleukin-1- and tumour-necrosis-factor-stimulated phospholipase A2 secretion from rat renal mesangial cells. Biochem J. 1991 Jan 1;273(Pt 1):199–204. doi: 10.1042/bj2730199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pfeilschifter J., Pignat W., Märki F., Wiesenberg I. Release of phospholipase A2 activity from rat vascular smooth muscle cells mediated by cAMP. Eur J Biochem. 1989 Apr 15;181(1):237–242. doi: 10.1111/j.1432-1033.1989.tb14717.x. [DOI] [PubMed] [Google Scholar]
  31. Pfeilschifter J., Schalkwijk C., Briner V. A., van den Bosch H. Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J Clin Invest. 1993 Nov;92(5):2516–2523. doi: 10.1172/JCI116860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Pritze S., Peskar B. A., Simmet T. Release of eicosanoids and endothelin in an experimental model of adult respiratory distress syndrome. Agents Actions Suppl. 1992;37:41–46. doi: 10.1007/978-3-0348-7262-1_6. [DOI] [PubMed] [Google Scholar]
  33. Radvanyi F., Jordan L., Russo-Marie F., Bon C. A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin. Anal Biochem. 1989 Feb 15;177(1):103–109. doi: 10.1016/0003-2697(89)90022-5. [DOI] [PubMed] [Google Scholar]
  34. Romaschin A. D., DeMajo W. C., Winton T., D'Costa M., Chang G., Rubin B., Gamliel Z., Walker P. M. Systemic phospholipase A2 and cachectin levels in adult respiratory distress syndrome and multiple-organ failure. Clin Biochem. 1992 Feb;25(1):55–60. doi: 10.1016/0009-9120(92)80046-j. [DOI] [PubMed] [Google Scholar]
  35. Schalkwijk C., Pfeilschifter J., Märki F., van den Bosch H. Interleukin-1 beta, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cells. Biochem Biophys Res Commun. 1991 Jan 15;174(1):268–275. doi: 10.1016/0006-291x(91)90515-9. [DOI] [PubMed] [Google Scholar]
  36. Schevitz R. W., Bach N. J., Carlson D. G., Chirgadze N. Y., Clawson D. K., Dillard R. D., Draheim S. E., Hartley L. W., Jones N. D., Mihelich E. D. Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Nat Struct Biol. 1995 Jun;2(6):458–465. doi: 10.1038/nsb0695-458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  38. Tannenbaum C. S., Hamilton T. A. Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. J Immunol. 1989 Feb 15;142(4):1274–1280. [PubMed] [Google Scholar]
  39. Uhlig S., Nüsing R., von Bethmann A., Featherstone R. L., Klein T., Brasch F., Müller K. M., Ullrich V., Wendel A. Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. Mol Med. 1996 May;2(3):373–383. [PMC free article] [PubMed] [Google Scholar]
  40. Vadas P., Stefanski E., Wloch M., Grouix B., Van Den Bosch H., Kennedy B. Secretory non-pancreatic phospholipase A2 and cyclooxygenase-2 expression by tracheobronchial smooth muscle cells. Eur J Biochem. 1996 Feb 1;235(3):557–563. doi: 10.1111/j.1432-1033.1996.t01-1-00557.x. [DOI] [PubMed] [Google Scholar]
  41. Vial D., Señorale-Pose M., Havet N., Molio L., Vargaftig B. B., Touqui L. Expression of the type-II phospholipase A2 in alveolar macrophages. Down-regulation by an inflammatory signal. J Biol Chem. 1995 Jul 21;270(29):17327–17332. doi: 10.1074/jbc.270.29.17327. [DOI] [PubMed] [Google Scholar]
  42. van den Bosch H. Intracellular phospholipases A. Biochim Biophys Acta. 1980 Sep 30;604(2):191–246. doi: 10.1016/0005-2736(80)90574-x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES